Animal research suggests new strategy for treating cocaine addiction

New research in monkeys suggests the feasibility of treating cocaine addiction with a “replacement” drug that mimics the effects of cocaine but has less potential for abuse – similar to the way nicotine and heroin addictions are treated.

Reporting at the annual meeting of the American Society of Pharmacology and Experimental Therapeutics in San Diego, Calif., scientists from Wake Forest University School of Medicine said treating monkeys with amphetamine significantly reduced their self-administration of cocaine for up to a month.

“This suggests the possibility of developing an amphetamine-like drug for treating cocaine addiction,” said Paul Czoty, Ph.D., lead author and assistant professor of physiology and pharmacology. “The research also demonstrates the usefulness for conducting studies in monkeys to test potential treatments.”

Czoty said the quest to develop a treatment for cocaine addiction has been ongoing for decades with little success. “While we have medications for heroin and tobacco abuse, there is no FDA-approved treatment for cocaine,” he said.

With both heroin and tobacco, there are treatments to replace the addictive drug with a drug that has similar effects on the body, but with less potential for abuse.

“With this strategy in mind, clinical researchers have turned to drugs currently available, including amphetamines,” said Czoty. “While it’s unlikely that amphetamine itself will turn out to be the best treatment, these drugs allow us to prove the concept of using a replacement drug to combat cocaine addiction.”

Amphetamines have been used in clinical studies with some success, said Czoty. His research in monkeys may help identify the best dose and schedule for administering a replacement drug – as well as evaluate potential treatment candidates and estimate potential side effects.

For the study, a monkey was taught to press levers multiple times to obtain food or a cocaine injection. With each injection, the number of required lever presses increased so that the animal had to work harder for the cocaine.

“This procedure measures the strength of the reinforcing effects of drugs,” said Czoty. “Each injection requires more and more work and eventually it gets to the point where it’s not worth it to the monkey because more than 1,000 presses are required.”

Access to cocaine was then removed and the monkey was treated intravenously with an amphetamine 24 hours per day. When re-exposed to cocaine one week later, a dramatic decrease in responding for cocaine was observed. They tested three different doses of amphetamine and found that a moderate dose was most effective. Although the treatment also decreased lever-pressing for food—which could be predictive of side effects in humans -- this effect disappeared within one week while the effect on responding for cocaine injections persisted for up to one month.

“This was a very positive finding – exactly what we had hoped to see,” said Czoty. “Cocaine use was significantly reduced – by about 60 percent.”

The researchers are currently repeating the study in additional animals. They hope it could eventually lead to identifying a slightly different drug that will obtain the same results as amphetamines.

Czoty said the study is significant because it and other similar studies in monkeys duplicate what has been found in small studies in humans, which suggests that the animal model can be used to test other treatments. The researchers, for example, plan to test topiramate (Topamax®), an anti-convulsant drug that is sometimes used to treat epilepsy and may be effective in treating alcoholism.

“We have found a model we can use to test new drugs and have an idea of what positive or negative effects would look like,” said Czoty.

Source: Wake Forest University

Related stories:

Biophysicists create new model for protein-cholesterol interactions in brain and muscle tissue
Biophysicists at the University of Pennsylvania have used 3,200 computer processors and long-established data on cholesterol's role in the function of proteins to clarify the mysterious interaction between cholesterol and neurotransmitter receptors. The results provide a new model of behavior for the nicotinic acetylcholine receptor, a well studied protein involved in inflammation, Alzheimer's disease, Parkinson's disease, schizophrenia, epilepsy, the effect of general anesthetics and addiction to alcohol, nicotine and cocaine.
Caffeine experts call for warning labels for energy drinks
Johns Hopkins scientists who have spent decades researching the effects of caffeine report that a slew of caffeinated energy drinks now on the market should carry prominent labels that note caffeine doses and warn of potential health risks for consumers.
'Erasing' drug-associated memories may stop drug addiction relapses
(PhysOrg.com) -- 'Erasing' drug-associated memories may prevent recovering drug abusers from relapsing, researchers at the University of Cambridge have discovered.
Cocaine-induced synaptic plasticity linked to persistent addictive behaviors
The persistent nature of addiction is its most devastating feature. Understanding the mechanism underlying this phenomenon is the key for designing efficient therapy. Two separate studies published by Cell Press is the August 14 issue of the journal Neuron identify specific cocaine-induced changes in dopamine (DA) neurons that play a pivotal role in behaviors associated with drug addiction.
Cocaine addiction linked to voluntary drug use and cellular memory
Rats that voluntarily use cocaine show a persistent cellular memory in the brain's reward center even after several months of abstinence from the drug, while their involuntary counterparts had no such memory, according to a new study by researchers at the University of California, San Francisco.
Brain's reaction to self-administered cocaine differs
New research has uncovered a fundamental cellular mechanism that may drive pathological drug-seeking behavior. The study, published by Cell Press in the July 31 issue of the journal Neuron, examines the brain's reward circuitry and details strikingly distinct influences of self-administered cocaine compared to natural rewards or passive cocaine injection.
Researchers discover how antidepressants and cocaine interact with brain cell targets
In a first, scientists from Weill Cornell Medical College and Columbia University Medical Center have described the specifics of how brain cells process antidepressant drugs, cocaine and amphetamines. These novel findings could prove useful in the development of more targeted medication therapies for a host of psychiatric diseases, most notably in the area of addiction.
Probing Question: Fishhooks of addiction
When the American writer Theodore Roethke taught at Penn State from 1936 to 1943, he was known for three things: being a good poet, coaching the men’s tennis team, and falling down drunk, perhaps the latter more than the former. Roethke, a brilliant and tortured man, knew well the seduction of drink and the agony of addiction. In his poem “Journey Into the Interior,” Roethke writes, “In the long journey out of the self, / There are many detours, washed-out interrupted raw places / Where the shale slides dangerously / And the back wheels hang almost over the edge / At the sudden veering, the moment of turning.”

News discussion:

General Science news